Puretech Health PLC - Adr (PRTCY) — Institutional Investor Activity (Q2 2026)

PRTCY ranks #31126 out of 37527 tracked stocks by institutional interest — a comparatively under-the-radar name outside the most closely tracked half.

Pentwater Capital Management LP has trimmed its PRTCY position for two straight quarters, cutting it by $347.3K while still holding $1.0M.

PRTCY is down 0% today, and institutions have been net sellers of $2.0M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

PRTCY reported a net loss of $110.1M in its latest fiscal year.

• Not yet profitable — net loss of $110.1M in the latest fiscal year
• Revenue declined 3.5% year over year
• Net income declined year over year, from $27.8M to -$110.1M
• Operating cash flow was negative, using $85.1M in cash
• Current ratio of 6.59x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.75x equity — within a conventional range